Synthesis, Molecular Docking and Preliminary Antileukemic Activity of 4‐Methoxybenzyl Derivatives Bearing Imidazo[2,1‐ b ][1,3,4]thiadiazole

Author:

Choodamani B.12ORCID,Cano Hernandez Karla G.3ORCID,Kumar Sujeet1ORCID,Tony Ann Maria4ORCID,Schiaffino Bustamante Austre Y.3ORCID,Aguilera Renato J.3ORCID,Schols Dominique5ORCID,Gopi Mohan C.4ORCID,Karki Subhas S.12ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry KLE College of Pharmacy (A Constituent Unit of KAHER-Belagavi) Bengaluru 560010 Karnataka India

2. Dr. Prabhakar B. Kore Basic Science Research Center, Off-Campus KLE College of Pharmacy (A Constituent Unit of KAHER-Belagavi) Bengaluru 560010 Karnataka India

3. The Cellular Characterization and Biorepository Core Facility and Border Biomedical Research Center and Department of Biological Sciences The University of Texas at El Paso El Paso 79968 TX USA

4. Center for Nanosciences and Molecular Medicine Amrita Institute of Medical Sciences and Research Center Amrita Vishwa Vidyapeetham Kochi 682041 Kerala India

5. Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation Laboratory of Virology and Chemotherapy, KU Leuven B-3000 Leuven Belgium

Publisher

Wiley

Subject

Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering

Reference49 articles.

1. American Cancer Society ‘Cancer Facts and Statistics’ (n.d.) Retrieved from https://cancerstatisticscenter.cancer.org/.

2. MD D. (n.d.) ‘Leukemia: An overview for primary care’ Retrieved from https://pubmed.ncbi.nlm.nih.gov/24784336/2.

3. ‘What Is Acute Lymphocytic Leukemia (ALL)?: Acute Lymphocytic Leukemia (ALL). (n.d.)’ Retrieved from https://www.cancer.org/cancer/acute-lymphocytic-leukemia/about/what-is-all.html.

4. ‘What Is Chronic Myeloid Leukemia?: Leukemia Types. (n.d.)’ Retrieved from https://www.cancer.org/cancer/chronic-myeloid-leukemia/about/what-is-cml.html.

5. ‘Chemotherapy for Acute Lymphocytic Leukemia (ALL). (n.d.)’ Retrieved from https://www.cancer.org/cancer/acute-lymphocytic-leukemia/treating/chemotherapy.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3